Literature DB >> 20938756

Comparative analysis of chemokine receptor's expression in mesenchymal stem cells derived from human bone marrow and adipose tissue.

Naghmeh Ahmadian Kia1, Ahmad Reza Bahrami, Marzieh Ebrahimi, Maryam M Matin, Zeinab Neshati, Mahmood Rais Almohaddesin, Naser Aghdami, Hamid Reza Bidkhori.   

Abstract

Mesenchymal stem cells (MSCs) are considered as promising candidates for new clinical trials of cell therapies. Bone marrow (BM) was the first source reported to contain MSCs; however, using it may be detrimental due to the highly invasive aspiration procedures. More recently, adipose tissue, attainable by a less invasive method, has been introduced as an alternative source of MSCs. So far, MSCs derived from these two sources have been compared in different characters; however, one of the main properties, i.e., the expression of chemokine receptors, has been ignored in these comparisons. In the present study, human MSCs were derived from bone marrow and adipose tissues and characterized by their expression of some cell surface antigens and also differentiation capacity. The expression of five selected chemokine receptors, which seems to be important in cell homing, was also compared. Semiquantitative reverse transcription-polymerase chain reaction method was used to assess gene expression levels of these chemokine receptors. Our results indicate that expression of these receptors in human MSCs, derived from adipose tissue, was higher than MSCs from bone marrow. Chemokine receptors and their ligands and adhesion molecules play an important role in tissue-specific homing of leukocytes and have also been implicated in trafficking of hematopoietic precursors into and through tissues. Therefore, MSCs from adipose tissue may show a better migration and homing capacity and they might be a better candidate for therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938756     DOI: 10.1007/s12031-010-9446-6

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  31 in total

1.  Isolation, characterization, and differentiation potential of canine adipose-derived stem cells.

Authors:  N M Vieira; V Brandalise; E Zucconi; M Secco; B E Strauss; M Zatz
Journal:  Cell Transplant       Date:  2009-12-08       Impact factor: 4.064

2.  Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells.

Authors:  Angela Kortesidis; Andrew Zannettino; Sandra Isenmann; Songtao Shi; Tsvee Lapidot; Stan Gronthos
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

3.  Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone.

Authors:  Juliana Croitoru-Lamoury; Francois M J Lamoury; John J Zaunders; Laura A Veas; Bruce J Brew
Journal:  J Interferon Cytokine Res       Date:  2007-01       Impact factor: 2.607

4.  Comparison of multi-lineage cells from human adipose tissue and bone marrow.

Authors:  Daniel A De Ugarte; Kouki Morizono; Amir Elbarbary; Zeni Alfonso; Patricia A Zuk; Min Zhu; Jason L Dragoo; Peter Ashjian; Bert Thomas; Prosper Benhaim; Irvin Chen; John Fraser; Marc H Hedrick
Journal:  Cells Tissues Organs       Date:  2003       Impact factor: 2.481

5.  Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas.

Authors:  A J A Deutsch; A Aigelsreiter; E Steinbauer; M Frühwirth; H Kerl; C Beham-Schmid; H Schaider; P Neumeister
Journal:  J Pathol       Date:  2008-08       Impact factor: 7.996

6.  The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation.

Authors:  Shyam Bhakta; Ping Hong; Omer Koc
Journal:  Cardiovasc Revasc Med       Date:  2006 Jan-Mar

7.  High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome.

Authors:  Quyen D Chu; Lori Panu; Neal T Holm; Benjamin D L Li; Lester W Johnson; Songlin Zhang
Journal:  J Surg Res       Date:  2008-10-16       Impact factor: 2.192

Review 8.  The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders.

Authors:  Shimon Slavin; Basan G S Kurkalli; Dimitrios Karussis
Journal:  Clin Neurol Neurosurg       Date:  2008-03-06       Impact factor: 1.876

9.  Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets.

Authors:  Valeria Sordi; Maria Luisa Malosio; Federica Marchesi; Alessia Mercalli; Raffaella Melzi; Tiziana Giordano; Nathalie Belmonte; Giuliana Ferrari; Biagio Eugenio Leone; Federico Bertuzzi; Gianpaolo Zerbini; Paola Allavena; Ezio Bonifacio; Lorenzo Piemonti
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

10.  Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.

Authors:  Zuo-Lin Xiang; Zhao-Chong Zeng; Zhao-You Tang; Jia Fan; Peng-Yuan Zhuang; Ying Liang; Yun-Shan Tan; Jian He
Journal:  BMC Cancer       Date:  2009-06-09       Impact factor: 4.430

View more
  32 in total

Review 1.  Mesenchymal stem cells in the pathogenesis and therapy of breast cancer.

Authors:  Christelle P El-Haibi; Antoine E Karnoub
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-12-21       Impact factor: 2.673

2.  Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury.

Authors:  Thomas M Fandel; Maarten Albersen; Guiting Lin; Xuefeng Qiu; Hongxiu Ning; Lia Banie; Tom F Lue; Ching-Shwun Lin
Journal:  Eur Urol       Date:  2011-08-04       Impact factor: 20.096

3.  Blastema cells derived from New Zealand white rabbit's pinna carry stemness properties as shown by differentiation into insulin producing, neural, and osteogenic lineages representing three embryonic germ layers.

Authors:  Morvarid Saeinasab; Maryam M Matin; Fatemeh B Rassouli; Ahmad Reza Bahrami
Journal:  Cytotechnology       Date:  2014-11-05       Impact factor: 2.058

4.  Targeted Delivery of CXCL9 and OX40L by Mesenchymal Stem Cells Elicits Potent Antitumor Immunity.

Authors:  Pan Yin; Liming Gui; Caihong Wang; Jingjing Yan; Min Liu; Lu Ji; You Wang; Bin Ma; Wei-Qiang Gao
Journal:  Mol Ther       Date:  2020-08-08       Impact factor: 11.454

5.  Involvement of TNF-α in differential gene expression pattern of CXCR4 on human marrow-derived mesenchymal stem cells.

Authors:  Rozita Ziaei; Maryam Ayatollahi; Ramin Yaghobi; Zeinab Sahraeian; Nosratollah Zarghami
Journal:  Mol Biol Rep       Date:  2014-01-07       Impact factor: 2.316

Review 6.  Mesenchymal stem cell therapy of intestinal disease: are their effects systemic or localized?

Authors:  Nicholas A Manieri; Thaddeus S Stappenbeck
Journal:  Curr Opin Gastroenterol       Date:  2011-03       Impact factor: 3.287

Review 7.  Human Mesenchymal Stem/Stromal Cells in Immune Regulation and Therapy.

Authors:  Éva Mezey
Journal:  Stem Cells Transl Med       Date:  2022-03-17       Impact factor: 6.940

8.  Obesity-associated dysregulation of calpastatin and MMP-15 in adipose-derived stromal cells results in their enhanced invasion.

Authors:  Amy L Strong; Julie A Semon; Thomas A Strong; Tatyana T Santoke; Shijia Zhang; Harris E McFerrin; Jeffrey M Gimble; Bruce A Bunnell
Journal:  Stem Cells       Date:  2012-12       Impact factor: 6.277

Review 9.  Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.

Authors:  Mark A Eckert; Quynh Vu; Kate Xie; Jingxia Yu; Wenbin Liao; Steven C Cramer; Weian Zhao
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-12       Impact factor: 6.200

Review 10.  Biological, chemical and mechanical factors regulating migration and homing of mesenchymal stem cells.

Authors:  Renata Szydlak
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.